These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 27658510)
1. Purinergic Signalling and Neurological Diseases: An Update. Burnstock G CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510 [TBL] [Abstract][Full Text] [Related]
2. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Burnstock G Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033 [TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling: from normal behaviour to pathological brain function. Burnstock G; Krügel U; Abbracchio MP; Illes P Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261 [TBL] [Abstract][Full Text] [Related]
4. Introduction to Purinergic Signaling. Burnstock G Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477 [TBL] [Abstract][Full Text] [Related]
5. Introduction to purinergic signalling in the brain. Burnstock G Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061 [TBL] [Abstract][Full Text] [Related]
6. Purinergic Signalling: Therapeutic Developments. Burnstock G Front Pharmacol; 2017; 8():661. PubMed ID: 28993732 [TBL] [Abstract][Full Text] [Related]
7. P2X and P2Y receptors—role in the pathophysiology of the nervous system. Puchałowicz K; Tarnowski M; Baranowska-Bosiacka I; Chlubek D; Dziedziejko V Int J Mol Sci; 2014 Dec; 15(12):23672-704. PubMed ID: 25530618 [TBL] [Abstract][Full Text] [Related]
8. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. Apolloni S; Montilli C; Finocchi P; Amadio S FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216 [TBL] [Abstract][Full Text] [Related]
9. Introduction to Purinergic Signalling in the Brain. Burnstock G Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706 [TBL] [Abstract][Full Text] [Related]
10. Purinergic signalling: past, present and future. Burnstock G Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040 [TBL] [Abstract][Full Text] [Related]
11. Physiopathological roles of P2X receptors in the central nervous system. Burnstock G Curr Med Chem; 2015; 22(7):819-44. PubMed ID: 25005189 [TBL] [Abstract][Full Text] [Related]
12. Purinergic signalling and disorders of the central nervous system. Burnstock G Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979 [TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors in psychiatric disorders. Krügel U Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371 [TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor: an emerging target in central nervous system diseases. Sperlágh B; Illes P Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574 [TBL] [Abstract][Full Text] [Related]
15. Introductory overview of purinergic signalling. Burnstock G Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101 [TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling in Alzheimer's disease. Erb L; Woods LT; Khalafalla MG; Weisman GA Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151 [TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators. Pan L; Ma Y; Li Y; Wu H; Huang R; Cai Z; Wu X Mini Rev Med Chem; 2021; 21(11):1288-1302. PubMed ID: 33302833 [TBL] [Abstract][Full Text] [Related]
20. Role of the purinergic signaling in epilepsy. Cieślak M; Wojtczak A; Komoszyński M Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]